In comparison to major acute medical pathologies,
the comparative dearth of novel therapeutic agents,
persistently high morbidity and significant mortality
that characterise sepsis syndrome is striking.1–5 A lack
of suitable human models that afford a methodologically
robust control population for mechanistic studies
may explain this lack of progress.